• Japanese
  • Korean
  • Chinese
Cover Image

Nanotechnology Drug Delivery Market in the US 2012-2016

Abstract

TechNavio's analysts forecast the Nanotechnology Drug Delivery market in the US to grow at a CAGR of 84.79 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R and D cost. The Nanotechnology Drug Delivery market in the US has also been witnessing the trend of emergence of personalized medicines. However, the increasing safety concerns could pose a challenge to the growth of this market.

TechNavio's report, the Nanotechnology Drug Delivery Market in the US 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. It also covers the Nanotechnology Drug Delivery market in the US landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space include Alkermes plc.,Celgene Corp., Novartis AG and SkyePharma plc .

Other vendors mentioned in the report are Merck and Co. Inc., Pfizer Inc., AlphaRx Inc., Amgen, Inc., Angiotech Pharmaceuticals, Inc., Biophan Technologies, Inc., Calando Pharmaceuticals, Inc., Cephalon, Inc., Cerulean Pharma, Inc, Copernicus Therapeutics, Inc., CritiTech, Inc., CytImmune Sciences, Inc., Elan Corporation, plc, Debiotech SA, F. Hoffmann-La Roche Ltd, Nano Interface Technology, Inc, Spherics, Inc., Spectrum Pharmaceuticals, Inc., SoluBest Ltd., Sigma-Tau Pharmaceuticals, Inc., PharmaNova Inc. Particle Sciences, Inc., Novavax, Inc., Nanotherapeutics, Inc., NanoSight Ltd., NanoCarrier Co. Ltd., NanoBioMagnetics, Inc., Nano Interface Technology, Inc, Merck Sharp and Dohme Corp., Kuecept Ltd., Izon Science Ltd.

Key questions answered in this report:

  • What will the market size be in 2016 and at what will be the growth rate?
  • What are key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by key vendors?
  • What are the strengths and weaknesses of each of these key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Scope of the Report

  • Market Overview

05. Market Landscape

  • 05.1. Nanotechnology Drug Delivery Market in the US
    • Market Size and Forecast
  • 05.2. Global Nanotechnology Drug Delivery Market Segmentation
  • 05.3. Five Force Analysis

06. Vendor Landscape

07. Buying Criteria

08. Market Growth Drivers

09. Drivers and their Impact

10. Market Challenges

11. Impact of Drivers and Challenges

12. Market Trends

13. Key Vendor Analysis

  • 13.1. Alkermes plc
    • Business Overview
    • Key Information
    • SWOT Analysis
  • 13.2. Celgene Corp.
    • Business Overview
    • Key Information
    • SWOT Analysis
  • 13.3. SkyePharma plc
    • Business Overview
    • SWOT Analysis
  • 13.4. Novartis AG
    • Business Overview
    • Key Information
    • SWOT Analysis

14. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Nanotechnology Drug Delivery Market in the US 2012-2016(US$ million)
  • Exhibit 2: Global Nanotechnology Drug Delivery Market Segmentation by Technology
  • Exhibit 3: Global Nanotechnology Drug Delivery Market Segmentation 2012(percent)
Show More
Pricing